Evaluation of DCTclock™ as a Cognitive Assessment Aid

Digital Cognition Technologies

Status: Completed

Conditions: Cognitive Function

Treatments: Device: DCTclock

Study type: Interventional

Funder types: Industry

Identifiers

NCT03238001

DCT032

Details and patient eligibility

About

The overall objective of this study is to demonstrate the safety and effectiveness of DCTclock as an adjunctive tool for use by clinicians to evaluate cognitive function in adults aged 55-95.

Enrollment: 450 patients

Sex: All

Ages: 55 to 95 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Men and women 55 to 95 years old.

Exclusion criteria

• Ineligible for written informed consent.
• Physical impairment of the writing hand.
• Impaired manual dexterity.
• Impaired vision.
• Under the influence of recreational drugs or alcohol at the time of the visit.
• Current or recent participation in a clinical trial that includes the use of a drug or intervention to alter cognitive function.
• Recent cognitive testing.

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

450 participants in 1 patient group

All qualified participants

Experimental group

Description:

Participants received DCTclock, Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and a battery of other traditional pen and paper neuropsychological assessments.

Treatment:

Device: DCTclock